Absolute neutrophil count (ANC) >= 1 x 10^9/L within 30 days of day 1 of studyXx_NEWLINE_xXMust have absolute neutrophil count ? 1.5 x 10^9/L within 14 days prior to randomization.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 750/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 10^9/L, within 28 days prior to administration of study treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L measured within 28 days prior to randomizationXx_NEWLINE_xXWithin less than or equal to 14 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXRE-REGISTRATION ELIGIBILITY CRITERIA (STEP 2): Absolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L within 14 days prior to registration.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000Xx_NEWLINE_xXObtained within 14 days prior to treatment start: Absolute neutrophil count >= 1.5 × 10^9/LXx_NEWLINE_xXFor patients with solid tumors, the following criteria apply: a. Hemoglobin ? 9.0 g/dl, b. Absolute lymphocyte count ? 1.0 x 10^9/L, c. Absolute neutrophil count ? 1.5 x 10^9/L, d. Platelets ? 100.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1,000/?LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9 cells/ LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >/= 1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count < 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count < 1.0 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXPeripheral absolute neutrophil count ? 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ?1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/L within 14 days of starting cycle 1 day 1 treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) greater than or equal to 1 x 10 to the ninth/LiterXx_NEWLINE_xXHave an absolute neutrophil count (ANC) ?1.0 × 109/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count > 1.5 x 10^9/LXx_NEWLINE_xXPHASE II INCLUSION CRITERIA: Absolute neutrophil count > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 × 10?9/Liter (L);Xx_NEWLINE_xXabsolute neutrophil count: ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXObtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXand absolute neutrophil count (ANC) ? 1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/L, determined within 14 days of registrationXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x 109/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 28 days of study registration: Absolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXWithin 28 days of study registration: Absolute lymphocyte count (ANC) >= 4.0 x 10^8/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 10^9/LXx_NEWLINE_xXANC ?1.5 x 10?/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support, at the screening visitXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x 10 (exp9)/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5×10?/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ?1.0×109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x10^9/LXx_NEWLINE_xXPlatelets ? 50 x 10^9/L; Hb ? 8.0 g/dL; absolute neutrophil count (ANC) ? 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 109/L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) <1.5 x 109/LXx_NEWLINE_xXNeutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 0.5 x 10^9/L (obtained =< 14 days prior to registration)Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1.5 x 10?/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) of >= 1.0 x 10^9/LXx_NEWLINE_xXNeutrophil count >= 1.5 x 10^9/lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.25 x 109/LXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) of at least 1,000/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXPatients must have absolute neutrophil count (ANC) >= 500 cells/L (0.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/?lXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 14 days of randomization: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 × 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 × 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1,000/µLXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXObtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 28 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (in absence of blood transfusion).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count <1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.0 × 10^9/L (Grade ?2).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 109/LXx_NEWLINE_xXObtained within 21 days prior to cycle 1, day 1: absolute neutrophil count (ANC) >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) =< 1.0Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 k/cummXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 750Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 10^9/L obtained ? 14 days prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 /LXx_NEWLINE_xXAbsolute peripheral neutrophil count (ANC) > 1,000.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3 within 10 days prior to “on study” statusXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells per LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 109/LXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) ?1.0 × 10^9/liter (L).Xx_NEWLINE_xXAbsolute neutrophil count >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 cells/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L in absence of growth factor supportXx_NEWLINE_xXWithin 14 days of the first study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 14 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/ LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXabsolute neutrophil count (ANC) ? 1.5 x 109/L;Xx_NEWLINE_xX(For both cohorts A and B): Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 cells/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^ 9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatmentXx_NEWLINE_xXSubjects with an absolute neutrophil count (ANC) of equal to or higher than 0.5 x 10^9 at the screening visitXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count levels < 0.5 × 10^9/L in the 4 weeks before screeningXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10 9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) count >= 1.5 X 10^9/LXx_NEWLINE_xXPatients must have an absolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9 /LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/L, within 14 days start of study startXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count greater than or equal to 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count < 1.0 x 10^9 /LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/L\r\n* By automated or manual review, whichever is greatestXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count =< 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXNeutrophil count of >= 1.0 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 0.5 x 10^9/L without daily use of myeloid growth factorXx_NEWLINE_xXNeutrophil count of >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 cell/mlXx_NEWLINE_xXAbsolute neutrophil count < 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/mm^3 [1.0 x 10^9/L]Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.0 x 109/l, hemoglobin ?8 g/dl, platelet count ? 100 x 10^9/l, prothrombin (INR) <1.5.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/mm^3 (1.0 x 10^9/L);Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 109 cells/LXx_NEWLINE_xXAbsolute neutrophil count ?1.5 x 109/L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/mm^3 (1.0 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x109/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXCERITINIB INCLUSION CRITERIA: Absolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 14 days prior to registration: Absolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 x 10^9 (International System [SI] units 10^9/L) (with or without filgrastim [G-CSF])Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 K/CUMMXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/µLXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (measured within 28 days prior to administration of study treatment)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count of < 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) <1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/L, obtained within 30 days of study registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXEvidence of neutrophil engraftment defined as the absolute neutrophil count (ANC) > 0.5 x 10^3/for 3 consecutive daysXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1,000Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXabsolute neutrophil count ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 0.75Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 0.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10 (3)uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) is >= 1,000Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L; ANC < 1.5 x 10^9/L if cytopenia is due to extensive bone marrow involvement of disease as determined by the treating physicianXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/L within 14 days prior to starting therapyXx_NEWLINE_xXWithin 14 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 750 X 10^9 /L without transfusion if stem cells are not availableXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/L (performed within 14 days prior to registration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 0.5 x 10^9/LXx_NEWLINE_xXIn patients < 18 years of age, moderately severe aplastic anemia is defined as having at least one of the following:\r\n* Platelet count < 40 x 10^9/L\r\n* Absolute neutrophil count (ANC) < 10 x 10^8/L\r\n* Hemoglobin (Hgb) < 9 g/dLXx_NEWLINE_xXWhite blood cell (WBC) > 2.5 x 10^9/L with an absolute neutrophil count (ANC) > 1.5 x 10^9/L and off G-CSF or sargramostim (GM-CSF_ for 10 days or pegfilgrastim (Neulasta) for 21 daysXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) <1.5 X 109/LXx_NEWLINE_xXANC ?1.5×10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/L; screening ANC should be independent of growth factor support for over one week for all patientsXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 100/LXx_NEWLINE_xXNeutrophil count >= 1.5 x 10^9/lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L within 28 days prior to administration of study treatment.Xx_NEWLINE_xXWithin 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) ? 1.5 x 10^9/LXx_NEWLINE_xXWithin 14 days of first dose of study drug: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 109 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXNeutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXWithin 14 days prior to first dose of study drug treatment: Absolute neutrophil count (ANC) >= 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 × 10^9/L =< 14 days prior to registrationXx_NEWLINE_xXWithin 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/ LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) >= 1.0 x 10^9 cells/ LXx_NEWLINE_xXAbsolute neutrophil count <1.0 × 10^9/L.Xx_NEWLINE_xXWithin 14 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXMeasured within 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/L within 2 weeks before baselineXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/L, within 2 weeks of the first dose of study treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 × 109/L within 14 days prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.5Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/lXx_NEWLINE_xXNeutrophil count < 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/L,Xx_NEWLINE_xXAbsolute neutrophil count (ANC):Xx_NEWLINE_xXNeutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/liter (L) andXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.0 X 10 9/L,Xx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/LXx_NEWLINE_xXabsolute neutrophil count ?1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/L without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXANC ?1.5×10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1000mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/lXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 109/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) < 1.5x109/LXx_NEWLINE_xXWithin 14 days of study start: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) <1.5 x 109/L (1.5x103/µL)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 0.75 x 10^9/L in the absence of growth factor in the prior 7 daysXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 (SI units 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^ 9/LXx_NEWLINE_xXPart 1: absolute neutrophil count (ANC) >= 1.5 x 10^9/L; Part 2: ANC >= 1.0 x 10^9/L if there is bone marrow involvement, >= 1.5 x 10^9/L if there is no bone marrow involvementXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5×109/LXx_NEWLINE_xXAbsolute neutrophil count < 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) must be > 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 109/L.Xx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9 /LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/L (within 7 days prior to registration)Xx_NEWLINE_xXHematologic absolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L obtained within 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXand absolute neutrophil count (ANC) ? 1.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) (neutrophil and bands) ?1.5 x 10 ^9/LXx_NEWLINE_xXANC ? 1.5 x 10?/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L without filgrastim (GCSF) support within 7 daysXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >=1.5 x 10^9/litre (L)Xx_NEWLINE_xXAbsolute neutrophil count =< 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 0.75 x 10^9/L in the absence of growth factor in the prior 7 daysXx_NEWLINE_xXAbsolute neutrophil count ?1.5 ×109/L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 109/L.Xx_NEWLINE_xXAt least 4 weeks (28 days) prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 750Xx_NEWLINE_xXAbsolute neutrophil count (ANC) <1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.0 × 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (tested within 14 days prior to registration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 X 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count < or equal to 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) =< 1.0Xx_NEWLINE_xXNeutrophil count >= 1.5 x 10^9/lXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= .750 x 10^9/LXx_NEWLINE_xXNeutrophil < 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1,000 (1.0 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (growth factors not permitted to make eligible)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC, calculated as the absolute number of neutrophils and bands) >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L or at least 1,500/mm^3 or at least 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 × 109/LXx_NEWLINE_xXAbsolute neutrophil count ?1.5 x 109/L,Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) <1,000/?L (1.0 X 109/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 cells/LXx_NEWLINE_xXPatient has an absolute neutrophil count of < 1.2 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.0 × 109/LXx_NEWLINE_xXAbsolute Neutrophil Count of at least 1.5 x 109/LXx_NEWLINE_xXAbsolute Neutrophil Count 75 x 10(9)/L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) of 750Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXEvidence of myeloid engraftment (absolute neutrophil count ?0.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.0 ×109/LXx_NEWLINE_xXAbsolute neutrophil count ?1,000/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000Xx_NEWLINE_xXHematological: Absolute neutrophil count (ANC) ? 1.5 x 10^9/L, platelet ? 100 x 10^9/L, hemoglobin ? 9 g/dLXx_NEWLINE_xXAbsolute neutrophil count ? 1,000/?L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) < 1.5 x 109/L Cardiac function:Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count of > 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 0.75 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.0 x 109/LXx_NEWLINE_xXAbsolute neutrophil count of >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.2 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1.5*10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L, unless due to bone marrow involvement with lymphomaXx_NEWLINE_xXAbsolute granulocyte count (ANC) >= 1.2 x 10^3/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/?lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count <1.5 x 10^9/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.5 x 10^9/L within 14 days prior to randomization.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count at least 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1.2x10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 10?/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9 cells/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 109/L.Xx_NEWLINE_xXWhole Blood Cells (WBC) ?3.0 x 10?/L, Absolute neutrophil count (ANC) ?1.5 x 10?/L and platelet count ?100 x 10?/LXx_NEWLINE_xXAbsolute neutrophil count >= 1000uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.0 x 109/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1.5 x 109/L.Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.0 x 109/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L and platelet count ?100 x 10^9/LXx_NEWLINE_xXThe patient has adequate bone marrow reserve: • Absolute neutrophil count (ANC) > 0.5 × 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) of ?1.0x109/L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1,000Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/LXx_NEWLINE_xXAbsolute neutrophil count ? 1.0 × 10^9/L within 21 days prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1000mm^3Xx_NEWLINE_xXabsolute neutrophil count (ANC) >=1.5*10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.0 x 10^9/L (without growth factor support)Xx_NEWLINE_xXNeutrophil count of >= 0.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor supportXx_NEWLINE_xXAbsolute neutrophil count of at least 1.5 × 109/L,Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 × 10^9/liter (L);Xx_NEWLINE_xXSubjects with an absolute neutrophil count (ANC) of equal to or higher than 0.5 x 10^9/L at the screening visitXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1200/mm^3 (>= 1.2 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 0.75 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 0.75 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1,000 cells/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXMeasured within 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXANC ? 1.0 x 10?/LXx_NEWLINE_xXAbsolute neutrophil count ³ 1.5 x 109/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/L (evaluated within 28 days of\r\nrandomization)Xx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L, within 2 weeks prior to study startXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count >= 1.5 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.2 X 10^9/LXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1.5 x 10E9/LXx_NEWLINE_xXAbsolute neutrophil count < 1.0 x 10^9/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1.5 x 109/LXx_NEWLINE_xXBone marrow reserve consistent with absolute neutrophil count (ANC) ?1.5*10^9/L; platelet count ?100*10^9/L; hemoglobin (Hgb) ?9 g/dL.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5x10^9/L;Xx_NEWLINE_xX